Alzheimer's Drug Discovery Foundation Announces Mark Roithmayr's Retirement as CEO
Position
Chief Executive Officer
Company
Alzheimer's Drug Discovery Foundation
New YorkBiotechnologyHealth CareDescription
Mark Roithmayr will retire as Chief Executive Officer of the Alzheimer's Drug Discovery Foundation effective December 31, 2025. The foundation's Board will oversee the search for a new CEO, while Roithmayr will remain in an advisory role during the transition.
Quick answer
Alzheimer's Drug Discovery Foundation Announces Mark Roithmayr's Retirement as CEO (April 24, 2025). Alzheimer's Drug Discovery Foundation is based in New York, New York, United States.
- What did Alzheimer's Drug Discovery Foundation announce on April 24, 2025?
- Mark Roithmayr will retire as Chief Executive Officer of the Alzheimer's Drug Discovery Foundation effective December 31, 2025. The foundation's Board will oversee the search for a new CEO, while Roithmayr will remain in an advisory role during the transition.
- What does Alzheimer's Drug Discovery Foundation do?
- The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease.
- Where is Alzheimer's Drug Discovery Foundation based?
- Alzheimer's Drug Discovery Foundation is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- Integer Holdings Corporation (April 24, 2025), Creyon Bio (April 24, 2025), Reframe Cancer (April 24, 2025) and Hansa Biopharma (April 24, 2025) also announced leadership changes within 45 days of Alzheimer's Drug Discovery Foundation.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Integer Holdings Corporation Appoints Payman Khales as President and CEO (April 24, 2025)
- Creyon Bio Appoints Serge Messerlian as CEO (April 24, 2025)
- Reframe Cancer Appoints Professor Ben Kelly as Chief Operating Officer (April 24, 2025)
- Hansa Biopharma Appoints Renée Aguiar-Lucander as Chief Executive Officer (April 24, 2025)
- CPTx Appoints McDavid Stilwell as Chief Financial Officer (April 24, 2025)
- Hercules Pharmaceuticals Appoints Randy Erickson as Chief Growth Officer (April 24, 2025)
Who to call at Alzheimer's Drug Discovery Foundation, and when
A new leader at Alzheimer's Drug Discovery Foundation brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Alzheimer's Drug Discovery Foundation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alzheimer's Drug Discovery Foundation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alzheimer's Drug Discovery Foundation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alzheimer's Drug Discovery Foundation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alzheimer's Drug Discovery Foundation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.